top of page

Newsroom
Learn more about Recolony bacteria-based cancer therapy, plus never miss an event.


Feb 11, 20221 min read
Our CEO wins a young women scientist award
Our CEO Ana Montalban-Arques is awarded with one of the Lyceum Awards to young women scientists in the category of Health Sciences. She...
47
0


Jan 25, 20221 min read
Werner Siemens Stiftung interviews Ana Montalban-Arques
Within the section "From lab to market" of the Werner Siemens Stiftung annual report 2021, our CEO Ana Montalban-Arques explains the...
28
0


Nov 7, 20211 min read
Our CEO wins the Falling Walls Breakthrough of Year in the Emerging Talents Category
Ana Montalban-Arques wins the Breakthrough of the Year in the Emerging Talents Category with the presentation “Breaking the Wall of...
67
0


Oct 15, 20211 min read
Our research gets featured in Cell Reports Medicine.
Our article "Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors" is highlighted in the...
57
0


Sep 28, 20211 min read
Ana Montalban-Arques wins Falling Walls Lab Switzerland
With the presentation entitled “Breaking the Wall of Ineffective Cancer Therapies” Ana won the 1st place in the competition and the...
50
0


Dec 10, 20201 min read
Ana Montalban-Arques receives support from the BRIDGE programme.
The project "Selected Clostridiales bacteria as novel treatment for solid tumors" has been awarded with the BRIDGE Proof of Concept...
26
0

Jun 8, 20201 min read
Ana Montalban-Arques receives 150.000CHF from the UZH Entrepreneur Fellowship
With the fellowship Ana Montalban-Arques will develop a formulation of a more storage-stable, lyophilized bacteria and test the efficacy,...
43
0
bottom of page